Drug regulator’s nod sought for phase-3 study of intranasal Covid vaccine in 5-18 age group
PTI, Sep 11, 2022, 11:08 AM IST
Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of its intranasal COVID-19 vaccine in the 5 to 18 age group.
On September 6, the Drugs Controller General of India (DCGI) had approved its intranasal Covid vaccine iNCOVACC for restricted emergency use in those aged above 18 years. ”Now the Hyderabad-based firm has submitted an application seeking permission to conduct phase-3, multicenter study to evaluate the safety, reactogenicity and immunogenicity of iNCOVACC (BBV154) in those aged 18 to 5 years,” an official source told PTI.
iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candidate was evaluated in phase 1, 2 and 3 clinical trials with successful results, a release from the vaccine-maker said.
BBV154 has been specifically formulated to allow intranasal delivery.
”Being an intranasal vaccine, BBV154 may produce local antibodies in the upper respiratory tract. These may provide the potential to reduce infection and transmission. Further studies are being planned,” the firm had said.
Separately, the DCGI also granted permission to the firm to conduct a phase-3 clinical trial to compare the immunogenicity and safety of BBV154 (intranasal) with Covaxin.
This trial has been permitted to be conducted at nine sites.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Nearsightedness is at epidemic levels – and the problem begins in childhood
Study finds genetic basis for link between depression, heart disease
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
Father’s diet can affect anxiety in sons, metabolism in daughters: Study in mice finds
MUST WATCH
Latest Additions
BJP seeking 400 seats to change Constitution, abolish reservations: Revanth Reddy
Congress accuses CPI(M) of hijacking poll machinery to bring down polling percentage
BJP banking on anti-incumbency, Modi factor to unseat BJD in Odisha: Tomar
Padubidri: Truck breaks down on NH after tyre burst
Uppinangady: Wedding called off after bride refuses to tie the knot at last minute